Free Trial

Amprius Technologies (NYSE:AMPX) Shares Down 4.8% - Here's What Happened

Amprius Technologies logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell 4.8% intraday to $16.11 on Thursday, with ~7.14 million shares traded (about 19% below average) after a prior close of $16.92.
  • Analysts are broadly positive — eight Buy vs. one Sell — giving a consensus rating of "Moderate Buy" and an average price target of $19.75, with several firms raising targets to $20.00.
  • Significant insider selling has occurred (4.65M shares worth ~$65.7M in the last 90 days, including large director sales), while the company beat quarterly EPS and revenue estimates but remains unprofitable (net margin -60.3%, FY2026 guidance EPS -0.060).
  • Five stocks we like better than Amprius Technologies.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report)'s stock price dropped 4.8% during trading on Thursday . The stock traded as low as $15.87 and last traded at $16.1050. Approximately 7,144,444 shares traded hands during mid-day trading, a decline of 19% from the average daily volume of 8,815,130 shares. The stock had previously closed at $16.92.

Analyst Upgrades and Downgrades

AMPX has been the subject of several research analyst reports. Weiss Ratings restated a "sell (e+)" rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. Roth Mkm restated a "buy" rating and issued a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a research report on Friday, March 6th. Needham & Company LLC restated a "buy" rating and issued a $20.00 price target on shares of Amprius Technologies in a research report on Tuesday, March 10th. Cantor Fitzgerald upped their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an "overweight" rating in a research report on Friday, March 6th. Finally, Oppenheimer restated an "outperform" rating and issued a $17.00 price target on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Eight equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $19.75.

Get Our Latest Analysis on Amprius Technologies

Amprius Technologies Stock Performance

The stock has a market cap of $2.21 billion, a price-to-earnings ratio of -47.37 and a beta of 2.20. The company's 50 day simple moving average is $14.35 and its two-hundred day simple moving average is $12.25.

Amprius Technologies (NYSE:AMPX - Get Free Report) last released its quarterly earnings data on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. The firm had revenue of $25.23 million for the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. On average, equities research analysts predict that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Insider Buying and Selling at Amprius Technologies

In other news, Director Wen Hsuan Hsieh sold 413,146 shares of the stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $18.44, for a total transaction of $7,618,412.24. Following the transaction, the director owned 44,444 shares in the company, valued at $819,547.36. This represents a 90.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Steven Chu sold 166,632 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $17.92, for a total transaction of $2,986,045.44. Following the transaction, the director owned 127,339 shares in the company, valued at approximately $2,281,914.88. This trade represents a 56.68% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 4,647,226 shares of company stock worth $65,744,047. Company insiders own 12.90% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of AMPX. Voloridge Investment Management LLC acquired a new position in Amprius Technologies in the 3rd quarter valued at $19,737,000. BNP Paribas Financial Markets grew its stake in Amprius Technologies by 1,117.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company's stock valued at $20,450,000 after buying an additional 1,784,291 shares during the last quarter. Vanguard Group Inc. grew its stake in Amprius Technologies by 37.0% in the 3rd quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company's stock valued at $68,513,000 after buying an additional 1,757,395 shares during the last quarter. Norges Bank acquired a new position in Amprius Technologies in the 4th quarter valued at $10,295,000. Finally, Invesco Ltd. grew its stake in Amprius Technologies by 113.3% in the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company's stock valued at $25,031,000 after buying an additional 1,263,846 shares during the last quarter. 5.04% of the stock is currently owned by institutional investors and hedge funds.

Amprius Technologies Company Profile

(Get Free Report)

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amprius Technologies Right Now?

Before you consider Amprius Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.

While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines